1. Home
  2. CTMX vs PMVP Comparison

CTMX vs PMVP Comparison

Compare CTMX & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • PMVP
  • Stock Information
  • Founded
  • CTMX 2008
  • PMVP 2013
  • Country
  • CTMX United States
  • PMVP United States
  • Employees
  • CTMX 122
  • PMVP N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • PMVP Medicinal Chemicals and Botanical Products
  • Sector
  • CTMX Health Care
  • PMVP Health Care
  • Exchange
  • CTMX Nasdaq
  • PMVP Nasdaq
  • Market Cap
  • CTMX 62.3M
  • PMVP 85.5M
  • IPO Year
  • CTMX 2015
  • PMVP 2020
  • Fundamental
  • Price
  • CTMX $0.80
  • PMVP $1.39
  • Analyst Decision
  • CTMX Buy
  • PMVP Strong Buy
  • Analyst Count
  • CTMX 6
  • PMVP 3
  • Target Price
  • CTMX $5.77
  • PMVP $5.33
  • AVG Volume (30 Days)
  • CTMX 730.8K
  • PMVP 121.2K
  • Earning Date
  • CTMX 03-10-2025
  • PMVP 02-27-2025
  • Dividend Yield
  • CTMX N/A
  • PMVP N/A
  • EPS Growth
  • CTMX N/A
  • PMVP N/A
  • EPS
  • CTMX 0.16
  • PMVP N/A
  • Revenue
  • CTMX $126,617,000.00
  • PMVP N/A
  • Revenue This Year
  • CTMX $22.55
  • PMVP N/A
  • Revenue Next Year
  • CTMX N/A
  • PMVP N/A
  • P/E Ratio
  • CTMX $5.14
  • PMVP N/A
  • Revenue Growth
  • CTMX 33.66
  • PMVP N/A
  • 52 Week Low
  • CTMX $0.75
  • PMVP $1.32
  • 52 Week High
  • CTMX $5.85
  • PMVP $2.26
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 41.61
  • PMVP 44.09
  • Support Level
  • CTMX $0.75
  • PMVP $1.35
  • Resistance Level
  • CTMX $0.98
  • PMVP $1.46
  • Average True Range (ATR)
  • CTMX 0.06
  • PMVP 0.04
  • MACD
  • CTMX 0.00
  • PMVP 0.00
  • Stochastic Oscillator
  • CTMX 20.13
  • PMVP 36.36

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.

Share on Social Networks: